Colorectal Cancer DNA Test Coverage Request Awaits Study Publication
This article was originally published in The Gray Sheet
Executive Summary
Exact Sciences will commence direct-to-consumer advertising for its PreGen-Plus fecal DNA colorectal cancer test in June while awaiting publication of multicenter study results in a peer-reviewed journal
You may also be interested in...
Colorectal Cancer DNA Test Cost, Health Benefit Questioned In NEJM Editorial
Exact Sciences' PreGen-Plus fecal DNA colorectal cancer screening test should not replace fecal occult blood tests due to unanswered questions about cost and health benefits, according to a Dec. 23 New England Journal of Medicine editorial
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.